Data is not available at this time.
Koei Chemical Company, Limited operates in the specialty chemicals sector, focusing on the production and global distribution of high-value chemical compounds. Its product portfolio includes ionic liquids, amines, methanol, pyridines, pyrazines, and formalin products, catering to diverse industrial applications such as pharmaceuticals, agrochemicals, and electronics. The company’s long-standing presence since 1917 underscores its established market position, leveraging technical expertise and a reputation for reliability in niche chemical markets. Koei Chemical differentiates itself through specialized formulations and a commitment to innovation, particularly in ionic liquids, which are increasingly used in green chemistry applications. While the company operates in a competitive global landscape, its focus on high-margin specialty chemicals provides resilience against commoditization pressures. Its headquarters in Tokyo and international sales network position it strategically to serve both domestic and export markets, though it faces challenges from raw material volatility and regulatory shifts in chemical manufacturing.
In FY 2024, Koei Chemical reported revenue of JPY 19.4 billion, with net income of JPY 299.6 million, reflecting modest profitability in a challenging cost environment. Operating cash flow stood at JPY 4.0 billion, indicating reasonable cash generation, though capital expenditures of JPY 2.1 billion suggest ongoing investments in production capabilities. The diluted EPS of JPY 61.26 highlights earnings scalability relative to its market cap.
The company’s earnings power is tempered by thin net margins (~1.5%), likely due to input cost pressures and competitive pricing. Operating cash flow coverage of capital expenditures (1.9x) demonstrates adequate reinvestment capacity, but elevated total debt (JPY 10.3 billion) raises questions about long-term capital efficiency, particularly given its JPY 562.9 million cash position.
Koei Chemical’s balance sheet shows significant leverage, with total debt exceeding cash reserves by ~18x. The debt burden may constrain financial flexibility, though its stable operating cash flow provides some mitigation. The modest cash balance relative to liabilities warrants monitoring, especially in light of potential industry cyclicality or supply chain disruptions.
Growth appears muted, with revenue and net income suggesting a focus on stability rather than expansion. The JPY 100 per share dividend implies a yield of ~1.6% (based on current market cap), aligning with conservative capital return policies common in Japanese industrials. Future growth may hinge on scaling high-value products like ionic liquids or geographic diversification.
At a market cap of ~JPY 10.9 billion, the company trades at ~0.56x revenue and ~36x net income, reflecting modest investor expectations. The low beta (0.104) suggests minimal correlation with broader market movements, typical for niche chemical firms with stable but unspectacular growth prospects.
Koei Chemical’s strengths lie in its specialized product mix and long-term industry relationships. However, its outlook is cautious, balancing opportunities in green chemistry against debt-related risks and margin pressures. Strategic initiatives to reduce leverage or expand high-margin segments could improve investor sentiment, though near-term headwinds persist.
Company filings, market data
show cash flow forecast
| Fiscal year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |